首页> 外文期刊>Diabetes >Diabetes Reduces Severity of Aortic Aneurysms Depending on the Presence of Cell Division Autoantigen 1 (CDA1)
【24h】

Diabetes Reduces Severity of Aortic Aneurysms Depending on the Presence of Cell Division Autoantigen 1 (CDA1)

机译:糖尿病会降低主动脉瘤的严重程度,具体取决于细胞分裂自身抗原1(CDA1)的存在

获取原文
获取原文并翻译 | 示例
       

摘要

Diabetes is a negative risk factor for aortic aneurysm, but the underlying explanation for this phenomenon is unknown. We have previously demonstrated that cell division autoantigen 1 (CDA1), which enhances transforming growth factor-β signaling, is upregulated in diabetes. We hypothesized that CDA1 plays a key role in conferring the protective effect of diabetes against aortic aneurysms. Male wild-type, CDA1 knockout (KO), apolipo-protein E (ApoE) KO, and CDA1/ApoE double-KO (dKO) mice were rendered diabetic. Whereas aneurysms were not observed in diabetic ApoE KO and wild-type mice, 40% of diabetic dKO mice developed aortic aneurysms. These aneurysms were associated with attenuated aortic transforming growth factor-p signaling, reduced expression of various collagens, and increased aortic macrophage infiltration and matrix metalloproteinase 12 expression. In the well-characterized model of angiotensin ll-induced aneurysm formation, concomitant diabetes reduced fatal aortic rupture and attenuated suprarenal aortic expansion, changes not seen in dKO mice. Furthermore, aortic CDA1 expression was downregu-lated ~70% within biopsies from human abdominal aortic aneurysms. The identification that diabetes is associated with upregulation of vascular CDA1 and that CDA1 deletion in diabetic mice promotes aneurysm formation provides evidence that CDA1 plays a role in diabetes to reduce susceptibility to aneurysm formation.
机译:糖尿病是主动脉瘤的消极危险因素,但对此现象的根本解释尚不清楚。先前我们已经证明,增强转化生长因子-β信号传导的细胞分裂自身抗原1(CDA1)在糖尿病中被上调。我们假设CDA1在赋予糖尿病对主动脉瘤的保护作用中起关键作用。使雄性野生型,CDA1敲除(KO),载脂蛋白E(ApoE)KO和CDA1 / ApoE double-KO(dKO)小鼠患有糖尿病。尽管在糖尿病ApoE KO和野生型小鼠中未观察到动脉瘤,但40%的糖尿病dKO小鼠发展为主动脉瘤。这些动脉瘤与主动脉转化生长因子-p信号减弱,各种胶原蛋白的表达减少以及主动脉巨噬细胞浸润和基质金属蛋白酶12表达增加有关。在充分表征的血管紧张素II诱导的动脉瘤形成模型中,伴随的糖尿病减少了致命的主动脉破裂并减弱了肾上主动脉扩张,这种变化在dKO小鼠中未见。此外,在人腹部主动脉瘤的活检组织中,主动脉CDA1的表达下降约70%。糖尿病与血管CDA1的上调相关以及糖尿病小鼠中CDA1缺失促进动脉瘤形成的鉴定提供了证据,表明CDA1在糖尿病中起到降低对动脉瘤形成的敏感性的作用。

著录项

  • 来源
    《Diabetes》 |2018年第4期|755-768|共14页
  • 作者单位

    Department of Diabetes, Central Clinical School, Monash University, Melbourne, Australia,Department of Immunology, Central Clinical School, Monash University, Melbourne, Australia,Diabetes Division, Baker IDI Heart and Diabetes Institute, Melbourne, Australia;

    Department of Diabetes, Central Clinical School, Monash University, Melbourne, Australia,Department of Immunology, Central Clinical School, Monash University, Melbourne, Australia,Diabetes Division, Baker IDI Heart and Diabetes Institute, Melbourne, Australia;

    Department of Diabetes, Central Clinical School, Monash University, Melbourne, Australia,Diabetes Division, Baker IDI Heart and Diabetes Institute, Melbourne, Australia;

    Department of Diabetes, Central Clinical School, Monash University, Melbourne, Australia,Diabetes Division, Baker IDI Heart and Diabetes Institute, Melbourne, Australia;

    Diabetes Division, Baker IDI Heart and Diabetes Institute, Melbourne, Australia;

    Department of Diabetes, Central Clinical School, Monash University, Melbourne, Australia,Diabetes Division, Baker IDI Heart and Diabetes Institute, Melbourne, Australia;

    Experimental Cardiology Laboratory, Baker IDI Heart and Diabetes Institute, Melbourne, Australia;

    Experimental Cardiology Laboratory, Baker IDI Heart and Diabetes Institute, Melbourne, Australia;

    Department of Medicine, Central Clinical School, Monash University, Melbourne, Australia,Department of Endocrinology and Diabetes, Alfred Hospital, Melbourne, Australia;

    Department of Diabetes, Central Clinical School, Monash University, Melbourne, Australia;

    Vascular Biology Unit, Queensland Research Centre for Peripheral Vascular Disease, James Cook University, Townsville, Australia;

    University of Queensland, Brisbane, Australia;

    Vascular Biology Unit, Queensland Research Centre for Peripheral Vascular Disease, James Cook University, Townsville, Australia,University of Queensland, Brisbane, Australia;

    Vascular Biology Unit, Queensland Research Centre for Peripheral Vascular Disease, James Cook University, Townsville, Australia,University of Queensland, Brisbane, Australia;

    Vascular Biology Unit, Queensland Research Centre for Peripheral Vascular Disease, James Cook University, Townsville, Australia,University of Queensland, Brisbane, Australia,Department of Vascular and Endovascular Surgery, Townsville Hospital, Townsville, Australia;

    Department of Diabetes, Central Clinical School, Monash University, Melbourne, Australia,Diabetes Division, Baker IDI Heart and Diabetes Institute, Melbourne, Australia;

    Department of Diabetes, Central Clinical School, Monash University, Melbourne, Australia,Department of Immunology, Central Clinical School, Monash University, Melbourne, Australia,Diabetes Division, Baker IDI Heart and Diabetes Institute, Melbourne, Australia;

    Department of Diabetes, Central Clinical School, Monash University, Melbourne, Australia,Department of Immunology, Central Clinical School, Monash University, Melbourne, Australia,Diabetes Division, Baker IDI Heart and Diabetes Institute, Melbourne, Australia;

  • 收录信息 美国《科学引文索引》(SCI);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-18 03:46:01

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号